Close Menu

More articles about Gene Silencing/Gene Editing

The company will now offer free genetic testing to patients at risk for acute hepatic porphyrias, a class of diseases for which it is developing a treatment.

Given the high yield of miRNA markers they were able to isolate, the researchers believe the approach could be commercialized for routine cancer testing.

The license is part of an ongoing cancer research collaboration between NovellusDx and Christiana Care's Gene Editing Institute.

Muneesh Tewari, a former Fred Hutchinson Cancer Research Center scientist who recently moved to the University of Mic

A research team led by investigators at Rockefeller University has developed a new method for detecting microRNAs in tissue samples, demonstrating its ability to differentiate skin cancer types based on tumor-specific miRNA signatures.

Pages